JAKARTA (Yosefardi) – Pharmaceutical company PT Pyridam Farma Tbk and GL Rapha Co Ltd/Hankook Korus Buopharm Co Ltd plans to build biopharmacy plant at 900 m2 land area.
Pyridam will hold 51% interest in the joint venture company while GL Rapha holds the rest. The biopharmacy plant will cost US$12 million.
The plant will produce erythropietin, PEG interferon alpha-2b, and human growth hormone.